WorkspaceResearch
ABOTPHARMACEUTICALSAlpha Score••Free accountSep-26

Abbot Laboratories (Pakistan) Ltd

Shariah compliant
Last close
Rs1,009
+0.35%
3 monthsAs of 19 Nov
BusinessStrongGrowthGrew 10%+last yearValueCore planHealthStrongDividendSteady

Almost no debt, a steady dividend, a strong business and the price in an uptrend. No read is against it.

Working

  • P/E 10.6 against a sector median of 11.9.
  • Debt is 1% of equity in the latest quarter.
  • Profit up 40% on the same quarter last year.

To watch

  • Revenue up 4% on the same quarter last year.
  • Yield 4.0% at today's price.
  • Raised last year, from Rs 10.00 to Rs 40.00.
Full analysis · free account

Keep reading ABOT: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, ABOT's sales rose 4% to Rs 20.6bn, from Rs 19.8bn, and profit after tax rose 40% to Rs 2.5bn, from Rs 1.8bn (compared with Jul–Sep 2025).

Earnings per share were Rs 25.99, against Rs 18.62 a year earlier.

At Rs 1009.02, ABOT trades at 11.1 times earnings, with a dividend yield of 4.0%.

P/E ratio
11.1
Dividend yield
4.0%
Dividend payout
0%
of earnings
Return on equity
27%
Net margin
12.0%
last 12 months
Debt to equity
0.01

ABOT quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 20.6bnRs 2.5bn12.3%Rs 25.99—
Apr–Jun 2026Rs 20.3bnRs 2.2bn10.8%Rs 22.47—
Jan–Mar 2026Rs 17.7bnRs 1.9bn11.0%Rs 19.82—
Oct–Dec 2025Rs 19.2bnRs 2.6bn13.6%Rs 26.56Rs 40.00
Jul–Sep 2025Rs 19.8bnRs 1.8bn9.2%Rs 18.62—
Apr–Jun 2025Rs 19.1bnRs 1.9bn10.2%Rs 19.85—
Jan–Mar 2025Rs 17.3bnRs 1.6bn9.2%Rs 16.34—
Oct–Dec 2024Rs 18.6bnRs 1.3bn6.9%Rs 13.12Rs 10.00

ABOT annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Dec 2025Rs 75.4bnRs 8.0bnRs 81.37Rs 40.00
Year to Dec 2024Rs 68.2bnRs 5.2bnRs 53.46Rs 10.00
Year to Dec 2023Rs 55.5bnRs 262.0mnRs 2.67—
Year to Dec 2022Rs 49.3bnRs 3.0bnRs 30.69Rs 15.00
Year to Dec 2021Rs 42.6bnRs 6.0bnRs 60.95Rs 40.00

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 50.2bn
Shareholders' equity
Rs 34.8bn
Cash & bank
Rs 10.4bn
Total debt
Rs 400.8mn
Current ratio
2.52
3-month high
Rs 1009.02
3-month low
Rs 896.88
1-month change
+7.8%
3-month change
+10.9%

Read more about ABOT

Other pharmaceuticals companies

ABOT: common questions

What is ABOT's share price?

Abbot Laboratories (Pakistan) Ltd (ABOT) last closed at Rs 1009.02 on the Pakistan Stock Exchange.

Does ABOT pay a dividend?

Yes. Abbot Laboratories (Pakistan) Ltd paid Rs 40.00 per share for the year to Dec 2025, and the stock's dividend yield is 4.0%.

What were ABOT's latest results?

In the Jul–Sep 2026 quarter, ABOT's sales rose 4% to Rs 20.6bn, from Rs 19.8bn, and profit after tax rose 40% to Rs 2.5bn, from Rs 1.8bn (compared with Jul–Sep 2025).

What is ABOT's P/E ratio?

At Rs 1009.02, ABOT trades at 11.1 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.